| __timestamp | Alnylam Pharmaceuticals, Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 6008900000 |
| Thursday, January 1, 2015 | 41097000 | 7853800000 |
| Friday, January 1, 2016 | 47159000 | 7063000000 |
| Sunday, January 1, 2017 | 76545000 | 6176000000 |
| Monday, January 1, 2018 | 73106000 | 6029000000 |
| Tuesday, January 1, 2019 | 194688000 | 6251000000 |
| Wednesday, January 1, 2020 | 414801000 | 5778000000 |
| Friday, January 1, 2021 | 704143000 | 6040000000 |
| Saturday, January 1, 2022 | 868601000 | 5760000000 |
| Sunday, January 1, 2023 | 1517886000 | 6198000000 |
| Monday, January 1, 2024 | 1924873000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceuticals, Alnylam Pharmaceuticals, Inc. and Bausch Health Companies Inc. present a fascinating study in contrasts. Over the past decade, Alnylam has seen a meteoric rise in its gross profit, surging from a modest $41 million in 2015 to an impressive $1.5 billion by 2023. This represents a staggering growth of over 3,600%, underscoring Alnylam's innovative approach and successful market strategies.
Conversely, Bausch Health, a stalwart in the industry, has maintained a steady gross profit, averaging around $6.3 billion annually. Despite fluctuations, Bausch's financial stability highlights its resilience and established market presence.
This juxtaposition of rapid growth versus steady performance offers valuable insights into the diverse strategies within the pharmaceutical sector. As Alnylam continues to innovate, and Bausch leverages its established base, both companies exemplify different paths to success in a competitive market.
Gross Profit Comparison: Johnson & Johnson and Bausch Health Companies Inc. Trends
Alnylam Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited: A Detailed Gross Profit Analysis
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Alkermes plc
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Veracyte, Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Vericel Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Generates Higher Gross Profit? Biogen Inc. or Bausch Health Companies Inc.
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Bausch Health Companies Inc.
Corcept Therapeutics Incorporated and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing MorphoSys AG and Bausch Health Companies Inc.